CPT code 0737T captures the surgical implantation of a nonhuman (xenogeneic) tissue graft onto the surface of a joint. This emerging procedure is relevant nationally as surgeons and payers navigate coverage for biologic implants intended to restore joint surface integrity and potentially delay or avoid joint replacement. Use of a specific CPT Category III code like 0737T signals an evolving technology with growing clinical interest and variable coverage policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for xenogeneic joint surface grafting, the settings where the procedure is performed, and the kinds of reimbursement and coding considerations that typically arise for new implant technologies. The publication summarizes available benchmarks and policy trends where documented and highlights gaps where payers or national guidelines have not issued firm coverage positions.

This summary equips clinicians, billing professionals, and policy analysts with the essential facts about CPT code 0737T, its clinical purpose, and the payer landscape to inform coding, claim submission, and administrative follow-up. Data not available in the input are noted in relevant sections of the full publication.